go back

Brexucabtagene Autoleucel (Tecartus)

Illinois rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $1,905,461 · 10th to 90th $676,083 to $5,370,318Professionalmedian $446,684 · 10th to 90th $446,684 to $446,684
$500K$1M$2M$5Mfacility $1,905,461professional $446,684

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
BCBS
Setting
Facility
Modifier
Global
Typical Low
$676,082.98
Median
$1,905,460.72
Typical High
$5,370,317.96
United
Setting
Professional
Modifier
Global
Typical Low
$446,683.59
Median
$446,683.59
Typical High
$446,683.59